# Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)

> **NCT04322682** · PHASE3 · TERMINATED · sponsor: **Montreal Heart Institute** · enrollment: 4506 (actual)

## Conditions studied

- Corona Virus Infection

## Interventions

- **DRUG:** Colchicine
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04322682
- **Lead sponsor:** Montreal Heart Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-03-23
- **Primary completion:** 2021-01-21
- **Final completion:** 2021-01-21
- **Target enrollment:** 4506 (ACTUAL)
- **Why stopped:** Due to several considerations (logistical, human and budgetary), the study was stopped early.
- **Last updated:** 2024-12-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04322682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04322682, "Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04322682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*